Condiciones de salud que Sophora puede ayudar a apoyar.
S. japonica is a primary commercial source of rutin and quercetin, both established antioxidants. Studies show S. japonica extracts boost superoxide dismutase and glutathione peroxidase activity and protect against lipid peroxidation. Antioxidant activity is documented in both in vitro and in vivo models.
Rutin from S. japonica aids in suppressing oxidative stress in arthritis patients and has strong anti-inflammatory and antioxidant properties relevant to joint inflammation. S. japonica is noted in pharmacological reviews for anti-osteoporotic and anti-arthritic activities. Matrine from S. flavescens also demonstrates anti-arthritic activity in preclinical models.
Rutin from S. japonica exhibits antiplatelet and antithrombotic properties demonstrated in pharmacological studies. Sophoricoside and quercetin have been shown to inhibit platelet aggregation and ACE activity. Research shows rutin can prevent blood clot formation in animal models by inhibiting platelet collagen-stimulated aggregation.
Quercetin and rutin from S. japonica have been shown to inhibit ACE and induce vasodilation in pharmacological models. S. japonica is listed in classical TCM for hypertension treatment. Some clinical literature on rutin evaluates blood pressure parameters, though results vary by dose and population.
S. flavescens is documented in Chinese folk and institutional medicine for type 2 diabetes management. Flavonoids including quercetin glycoside inhibitors reduce blood glucose. S. flavescens EtOAc extract significantly decreased fasting blood glucose in T2DM rats, and S. japonica extract reduced blood glucose in high-fat diet models.
S. flavescens extract demonstrates in vitro antifungal activity against multiple Candida species including drug-resistant strains. Phytochemical screening has identified flavonoids and alkaloids as active antifungal agents. One human case report documents S. flavescens use for vulvovaginal candidiasis.
Animal studies demonstrate that S. japonica extract reduces total cholesterol, raises HDL-cholesterol, and lowers LDL-cholesterol in high-fat diet models. Rutin at 500 mg/day reduced plasma LDL in diabetic hypertensive patients in a human study. Quercetin glycosides also show lipid-lowering potential by inhibiting LDL oxidation.
Sophora flavescens alkaloids (matrine, oxymatrine) and flavonoids (rutin, quercetin) from both Sophora species demonstrate anti-inflammatory activity in multiple in vitro and in vivo studies. Flavonoid constituents suppress pro-inflammatory cytokines including TNF-α, IL-1β, and IL-6. These mechanisms are supported by pharmacological research and form the basis of licensed TCM preparations.
S. japonica is listed in TCM as one of the 50 fundamental herbs specifically for circulatory system health. Rutin strengthens capillaries and improves blood flow. Troxerutin and hydroxyethylrutosides (rutin derivatives from S. japonica) have clinical evidence for improving venous circulation in chronic venous insufficiency.
S. japonica is linked to cognitive benefits and longevity in traditional Korean and Chinese medicine texts. A registered randomized double-blind placebo-controlled trial (100 participants aged 40–70) is currently evaluating S. japonica extract for subjective memory complaints. Quercetin and rutin from the plant demonstrate neuroprotective properties in preclinical models.
Oxymatrine from S. flavescens is commonly used in China to treat ulcerative colitis, with multiple licensed formulations. A 2025 systematic review and meta-analysis of 12 preclinical studies confirmed oxymatrine's efficacy in IBD models. Human RCT meta-analyses of Five-Flavor Sophora Enteric-Coated Capsules (containing S. flavescens) for UC have been published.
S. flavescens alkaloids (matrine, oxymatrine) and flavonoids reduce inflammatory markers in contact dermatitis and atopic dermatitis models. Topical Sophora application in mice with contact dermatitis decreased IFN-γ, TNF-α, and inhibited mast cell degranulation. Multiple preclinical studies confirm anti-dermatitic activity.
S. flavescens (Ku Shen) has been clinically used to treat eczema and atopic dermatitis in Chinese medicine, with licensed preparations available. Matrine and oxymatrine reduce key inflammatory cytokines (TNF-α, IL-4) in eczema models. Animal studies confirm dose-dependent skin lesion improvement comparable to dexamethasone.
Oxymatrine from S. flavescens has been studied for cardioprotective and anti-arrhythmic effects in preclinical models. Flavonoids from S. japonica improve circulation, reduce platelet aggregation, and lower oxidative stress relevant to cardiovascular health. Multiple pharmacological reviews confirm cardiovascular applications of Sophora-derived compounds.
Sophora japonica is one of the most historically documented remedies for hemorrhoids in TCM, listed in both the Chinese Pharmacopoeia and European Pharmacopoeia for this use. Its rutin content strengthens capillary walls and reduces venous inflammation. Hydroxyethylrutosides—semisynthetic derivatives of rutin originally sourced from S. japonica—have demonstrated clinical benefit in venous disorders including hemorrhoids.
S. flavescens-derived oxymatrine has been used to treat IBD in China and is the subject of a 2025 systematic review and meta-analysis of preclinical studies. Multiple clinical studies suggest Kushen extract formulations demonstrate efficacy in IBD patients. Evidence spans both ulcerative colitis and Crohn's-relevant inflammatory pathways.
Oxymatrine and matrine from S. flavescens are approved in China for treatment of chronic hepatitis B and have documented hepatoprotective, anti-fibrotic, and antiviral properties. S. flavescens extract reduces liver injury markers (ALT, AST) in alcohol-induced liver disease models and has anti-hepatic fibrosis effects.
S. flavescens alkaloids and flavonoids have been studied in psoriasis models and clinical applications. Oxymatrine is documented as used for plaque psoriasis. Matrine and S. flavescens-derived microneedles reduce psoriasiform lesions by inhibiting mast cells and TNF-α in animal models.
S. japonica extract reduced hepatic and serum triglycerides in high-fat diet animal models. Kaempferol glycosides and quercetin from the plant may decrease triglyceride levels. Preclinical evidence is consistent, though human-specific triglyceride RCTs are limited.
Hydroxyethylrutosides (oxerutins), semisynthetic derivatives of rutin from S. japonica, have been used clinically in the treatment of varicose veins and chronic venous disorders. Rutin strengthens capillary walls and reduces venous permeability, providing pharmacological rationale for this application.
Oxymatrine and matrine from S. flavescens have established antiviral activity against hepatitis B virus, with Chinese regulatory approval for this use. Multiple clinical trials document positive antiviral outcomes in chronic HBV. Additional antiviral activity against other viruses is under investigation.
S. japonica and S. flavescens are documented in TCM for intestinal disorders, dysentery, and abdominal conditions associated with damp-heat. Their use for gastrointestinal discomfort is recorded in classical Chinese pharmacopeias and modern ethnopharmacological reviews.
Sophora root (Ku Shen) is documented in TCM for purulent damp oozing sores and abscesses. Its antimicrobial alkaloids and flavonoids provide mechanistic rationale. The Chinese Pharmacopoeia recognizes Sophora for skin infections associated with heat and dampness patterns.
Sophora root (Ku Shen) is documented in TCM for treating pyoderma (skin purulence) and skin conditions attributed to damp-heat, including acne. Its antimicrobial and anti-inflammatory properties provide mechanistic support, and it is noted in herbal medicine references for acne applications.
S. japonica has been traditionally used for arteriosclerosis, documented in classical TCM pharmacopeias and ethnopharmacological reviews. Rutin and quercetin mechanistically support arterial integrity by inhibiting LDL oxidation and reducing capillary fragility. Preclinical evidence supports anti-atherogenic effects, though clinical trials are absent.
S. flavescens (Ku Shen) has a documented traditional use for diarrhea and dysentery in Chinese medicine, recorded in the Compendium of Materia Medica from the Ming dynasty. Alkaloids with antimicrobial and anti-inflammatory intestinal activity provide a plausible mechanism.
S. flavescens root is documented in classical TCM as an antipyretic medicine to reduce fever. This use is recorded in classical herbal texts and referenced in PubMed-indexed ethnopharmacological studies. Modern pharmacological data on antipyretic mechanisms are limited.
Sophora flavescens (Ku Shen) is traditionally used for fungal skin infections including tinea and scabies. TCM texts document its use for boils, fungal infections, and oozing sores. Preclinical antifungal activity has been demonstrated against multiple fungal pathogens.
S. japonica is documented in classical TCM pharmacopeias for headache and dizziness treatment, recognized alongside hypertension management. This use is recorded in PubMed-indexed ethnopharmacological reviews and TCM classical texts. The blood pressure-lowering and vasodilatory properties of rutin and quercetin provide mechanistic plausibility.
S. japonica has been used in traditional Chinese medicine to treat hemorrhinia (nosebleed) alongside other bleeding conditions. This use is documented in classical TCM pharmacopeias and ethnopharmacological reviews. The hemostatic and capillary-strengthening properties of rutin provide a plausible mechanism, though dedicated clinical trials for epistaxis are lacking.
Sophora flavescens has been traditionally used for antiparasitic purposes, including scabies and other skin parasites, documented in classical TCM texts. Its alkaloids have demonstrated antiparasitic activity in preclinical research. TCM references its use for clearing insects and parasites.
Sophora root (Ku Shen) is cited in TCM references for rosacea due to damp heat, with rutin's capillary-stabilizing properties mechanistically relevant to this condition. Vascular fragility and inflammation reduction by rutin may alleviate rosacea symptoms. Evidence remains traditional and mechanistic rather than from clinical trials.
Rutin from S. japonica is traditionally used and mechanistically studied for strengthening capillaries and improving conditions including spider veins. The capillary-strengthening and flexibility-improving properties of rutin provide a pharmacological rationale, though dedicated spider vein clinical trials are lacking.
Sophora extracts have been applied topically for skin lesions and sores in TCM, with rutin and quercetin providing antioxidant and anti-inflammatory support for wound healing. Preclinical data and traditional documentation support this use, though dedicated wound healing RCTs are lacking.
Volver